Susquehanna International Group, LLP Delcath Systems, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$7.36 - $11.0 $19,136 - $28,600	2,600 Added 16.25%	18,600 $167,000
Q2 2024 Aug 15, 2024	SELL	$4.47 - $8.37 $45,147 - $84,536	-10,100 Reduced 38.7%	16,000 $133,000
Q1 2024 May 07, 2024	BUY	$3.72 - $5.09 $45,756 - $62,607	12,300 Added 89.13%	26,100 $124,000
Q4 2023 Feb 14, 2024	SELL	$2.25 - $4.17 $32,850 - $60,882	-14,600 Reduced 51.41%	13,800 $57,000
Q3 2023 Nov 14, 2023	BUY	$3.12 - $5.85 $88,608 - $166,140	28,400 New	28,400 $115,000

7.62M

198K

41.7K

Ticker DCTH
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,597,680
Market Cap $83.9M
Description
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.